Dr. Kathryn Lancaster is an Investigator with Central Africa IeDEA and has been actively involved in the consortium since 2017. She is an infectious disease epidemiologist and implementation scientist with over 15 years of experience working at the intersection of substance use and HIV/STIs in both U.S. and global contexts. Using the lens of implementation science, she conducts research to advance the use of evidence-based interventions through human-centered design approaches and hybrid effectiveness–implementation trials. She serves as a Principal Investigator on several NIDA-funded studies focused on substance use and HIV prevention and care. She serves on the editorial board of Implementation Science Communications. She is also the Chair of the IeDEA Substance Use Working Group, where she leads cross-regional projects to strengthen the evidence base on substance use and HIV and inform programmatic and policy decision-making.
Dr. Lancaster holds a PhD in Epidemiology from the University of North Carolina at Chapel Hill, Gillings School of Global Public Health, and an MPH in Epidemiology from Tulane University School of Public Health and Tropical Medicine. She is an Associate Professor in the Department of Implementation Science at Wake Forest University School of Medicine.